426 related articles for article (PubMed ID: 18205213)
21. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection.
Endo R; Yoshioka M; Ebihara T; Ishiguro N; Kikuta H; Kobayashi K
Med Hypotheses; 2004; 63(4):582-7. PubMed ID: 15325000
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas.
Szkaradkiewicz A; Kruk-Zagajewska A; Wal M; Jopek A; Wierzbicka M; Kuch A
Clin Exp Med; 2002 Nov; 2(3):137-41. PubMed ID: 12447611
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
24. Association of Epstein-Barr virus with lymphoepithelioma-like carcinoma of the lung in southern China.
Han AJ; Xiong M; Zong YS
Am J Clin Pathol; 2000 Aug; 114(2):220-6. PubMed ID: 10941337
[TBL] [Abstract][Full Text] [Related]
25. [In situ detection of Epstein-Barr virus in the non-neoplastic gastric glands and infiltrated lymphocytes].
Sasaki Y; Hayashi K; Suzuki T; Toyoshima A; Teragawa M; Gouda S; Amimoto K; Matsui S; Yamane Y; Chen HL; Ohara N; Teramoto N; Akagi T
Rinsho Byori; 1996 Dec; 44(12):1196-200. PubMed ID: 8990940
[TBL] [Abstract][Full Text] [Related]
26. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
[TBL] [Abstract][Full Text] [Related]
27. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
[TBL] [Abstract][Full Text] [Related]
28. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
Meerbach A; Friedrichs C; Thust R; Wutzler P
Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
[TBL] [Abstract][Full Text] [Related]
30. Healthy rabbits are susceptible to Epstein-Barr virus infection and infected cells proliferate in immunosuppressed animals.
Khan G; Ahmed W; Philip PS; Ali MH; Adem A
Virol J; 2015 Feb; 12():28. PubMed ID: 25851649
[TBL] [Abstract][Full Text] [Related]
31. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
[TBL] [Abstract][Full Text] [Related]
32. [Adoptive transfer of Epstein-Barr virus-specific T-lymphocytes in chronic active Epstein-Barr infection].
Babel N; Hammer MH; Reinke P
Dtsch Med Wochenschr; 2003 Mar; 128(11):548-50. PubMed ID: 12635027
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus (HHV-4) inoculation to rabbits by intranasal and oral routes results in subacute and/or persistent infection dissimilar to human disease.
Rajčáni J; Szenthe K; Durmanová V; Tóth A; Asványi B; Pitlik E; Stipkovits L; Szathmary S
Intervirology; 2014; 57(5):254-69. PubMed ID: 24993954
[TBL] [Abstract][Full Text] [Related]
34. [Primary infection with Epstein-Barr virus in a 77-year-old patient with B symptoms and hepatitis -- a case report].
Drebber U; Kasper HU; Odenthal M; Kern MA; Feigk B; Dippold WG; Dienes HP
Z Gastroenterol; 2006 May; 44(5):387-90. PubMed ID: 16688655
[TBL] [Abstract][Full Text] [Related]
35. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.
Edson CM; Cohen LK; Henle W; Strominger JL
J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus in autoimmune diseases.
Toussirot E; Roudier J
Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):883-96. PubMed ID: 19028369
[TBL] [Abstract][Full Text] [Related]
37. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
38. Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives.
Besson C; Amiel C; Le-Pendeven C; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Abel L; Nicolas JC
J Clin Microbiol; 2006 Jan; 44(1):47-50. PubMed ID: 16390946
[TBL] [Abstract][Full Text] [Related]
39. Biology of Epstein-Barr virus during infectious mononucleosis.
Sitki-Green DL; Edwards RH; Covington MM; Raab-Traub N
J Infect Dis; 2004 Feb; 189(3):483-92. PubMed ID: 14745706
[TBL] [Abstract][Full Text] [Related]
40. Neurological complications of acute and persistent Epstein-Barr virus infection in paediatric patients.
Häusler M; Ramaekers VT; Doenges M; Schweizer K; Ritter K; Schaade L
J Med Virol; 2002 Oct; 68(2):253-63. PubMed ID: 12210416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
